Sask. confirms first case of blood clot after AstraZeneca vaccine – fr

0
10
Sask. confirms first case of blood clot after AstraZeneca vaccine – fr


REGINA – Saskatchewan has reported its first vaccine-related blood clot in a 60-year-old woman who received the AstraZeneca vaccine.

According to the government, the woman suffered vaccine-induced immune thrombotic thrombocytopenia – also known as VITT – after receiving the vaccine on April 11. She received treatment and is recovering.

The province has said it will continue to offer second doses equal to the first dose a person receives. The government acknowledged that a review of the brand blending for the first and second plans is underway and said its strategy may be updated depending on the outcome of the review.

Health officials said on Tuesday that they are currently only using AstraZeneca to deliver second doses due to limited availability.

According to the Public Health Agency of Canada (PHAC), there were 18 confirmed reports of VITT in the country on Wednesday. The province said it had reported the confirmed case to PHAC.

As of May 1, nearly 2,050,000 initial doses of AstraZeneca had been administered across Canada. Saskatchewan has administered approximately 72,000 initial doses of AstraZeneca to date, depending on the province.

LEAVE A REPLY

Please enter your comment!
Please enter your name here